The THYCOVIT (Thyroid Surgery during COVID-19 pandemic in Italy) study: results from a nationwide, multicentric, case-controlled study - Scorecard - MDSpire

The THYCOVIT (Thyroid Surgery during COVID-19 pandemic in Italy) study: results from a nationwide, multicentric, case-controlled study

  • By

  • Fabio Medas

  • Gian Luca Ansaldo

  • Nicola Avenia

  • Giancarlo Basili

  • Marco Boniardi

  • Marco Bononi

  • Aldo Bove

  • Paolo Carcoforo

  • Andrea Casaril

  • Giuseppe Cavallaro

  • Maria Grazia Chiofalo

  • Giovanni Conzo

  • Loredana De Pasquale

  • Paolo Del Rio

  • Gianlorenzo Dionigi

  • Chiara Dobrinja

  • Giovanni Docimo

  • Giuseppa Graceffa

  • Maurizio Iacobone

  • Nadia Innaro

  • Celestino Pio Lombardi

  • Nicola Palestini

  • Francesco Pedicini

  • Giuliano Perigli

  • Angela Pezzolla

  • Gregorio Scerrino

  • Stefano Spiezia

  • Mario Testini

  • Pietro Giorgio Calò

  • April 16, 2021

  • 0 min

Share

Clinical Scorecard: Findings from the THYCOVIT Study: An Analysis of Thyroid Surgery During the COVID-19 Pandemic in Italy Through a Nationwide, Multicentric, Case-Control Approach

At a Glance

CategoryDetail
ConditionThyroid disease requiring surgery, including thyroid malignancies, hyperthyroidism, and multinodular goitre with compressive symptoms
Key MechanismsImpact of COVID-19 pandemic on surgical activity and care delivery for thyroid disease; disruption due to resource reallocation and infection control measures
Target PopulationPatients undergoing thyroidectomy in Italy during the COVID-19 pandemic phases compared to the previous year
Care SettingEndocrine Surgical Units affiliated with the Italian Society of Endocrine Surgery (SIUEC) across Italy

Key Highlights

  • Significant reduction in thyroid surgical activity during COVID-19 pandemic phases due to national lockdown and healthcare resource reallocation
  • Maintenance of surgical treatment for thyroid malignancies was evaluated to assess adequacy despite pandemic constraints
  • Post-operative complication rates and tumor aggressiveness were monitored to verify maintenance of standard of care

Guideline-Based Recommendations

Diagnosis

  • Use of intraoperative nerve monitoring (IONM) to detect recurrent laryngeal nerve injury during thyroidectomy
  • Post-operative fibrolaryngoscopy to assess vocal fold mobility if RLN injury is suspected
  • Definition of post-surgical hypoparathyroidism based on PTH levels, calcemia, and need for calcium/vitamin D supplementation

Management

  • Prioritize thyroidectomy for malignancies and symptomatic conditions during pandemic phases while balancing infection risk
  • Adapt surgical scheduling according to epidemiological phases and government restrictions
  • Implement strategies to reduce nosocomial COVID-19 infection risk to patients and staff

Monitoring & Follow-up

  • Monitor incidence of post-operative complications including hypoparathyroidism, hematoma, and RLN injury
  • Track pathological features such as tumor size, lymph node metastases, extra-thyroidal extension, and multi-centricity
  • Evaluate delays in treatment for potential impact on tumor aggressiveness

Risks

  • Risk of delayed surgical treatment leading to progression or increased aggressiveness of thyroid malignancies
  • Increased risk of nosocomial COVID-19 infection during hospital stay
  • Potential reduction in surgical workforce and resources affecting care quality

Patient & Prescribing Data

Patients undergoing thyroidectomy during COVID-19 pandemic phases in Italy

Surgical activity was reduced overall, but efforts were made to maintain treatment for malignancies; standard of care including complication rates was monitored to ensure quality despite pandemic constraints

Clinical Best Practices

  • Classify patients and surgical scheduling according to pandemic epidemiological phases and government-imposed restrictions
  • Use intraoperative nerve monitoring routinely to minimize RLN injury
  • Perform post-operative fibrolaryngoscopy when vocal fold dysfunction is suspected
  • Define and monitor hypoparathyroidism using biochemical criteria and clinical supplementation needs
  • Collect and analyze aggregate data to assess impact of pandemic on surgical outcomes and adapt care accordingly

References

Original Source(s)

Related Content